Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Today, a crushing Phase 3 failure for Ultragenyx in Angelman syndrome, a new accelerator from Nobel laureate David Baker to use AI to map nature’s design rules, and more.

The sniffly 5-year-old in my bed is coloring a remarkable green-blue rainbow at present. Visionary, truly.

Continue to STAT+ to read the full story…